Summary
Aerocrine AB (Aerocrine) is a medical technology company. It sells medical technology products and tests for the application in healthcare industry. The company offers its products for diagnosis, treatment and monitoring of patients suffering from inflammation of airways. Its flagship products are marketed under the brand names, NIOX MINO, and NIOX VERO, handheld instruments which measure nitric oxide (NO) levels in exhaled air. Aerocrines products also find applications in research performed on respiratory diseases. The company offers these products to hospitals, research clinics, and healthcare units. It operates through wholly owned subsidiaries in the US, the UK, Sweden. Switzerland, and German markets and through suppliers and distributors in other regions such as Japan, Canada, Poland, Portugal, Spain, Australia, and South America among others. Aerocrine is headquartered in Solna, Sweden.
The company focuses on expanding its market presence by entering into agreements with established players in the industry. This is evident from recent signing of an exclusive agreement with Healthcare 21 Ltd for sales, marketing and distribution of its new airway inflammation monitor and test kit NIOX VERO in the UK and Ireland.
Aerocrine AB (AERO B) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Aerocrine AB, Medical Equipment Deals By Type, 2009 to YTD 2015 7
Aerocrine AB, Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Aerocrine AB, Medical Equipment, Deals By Market, 2009 to YTD 2015 9
Aerocrine AB, Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Aerocrine AB, Medical Equipment, Deal Details 11
Asset Purchase 11
Aerocrine Acquires FENO Assets From FILT 11
Aerocrine Completes Acquisition Of Assets From Apieron 12
Partnerships 13
Aerocrine Enters Into Licensing Agreement With Medisoft 13
Aerocrine Enters Into Distribution Agreement With Shanghai Pharma For Niox Mino And Test Kits 14
Aerocrine Enters Into Distribution Agreement With Stallergenes For Niox Mino 16
Aerocrine To Terminate Distribution Agreement With Thermo Fisher For Niox Mino 18
Aerocrine Enters Into Co-Development Agreement With FILT 19
Aerocrine Enters Into Co-Development Agreement With Panasonic Shikoku Electronics 20
Equity Offering 21
Aerocrine Completes Private Placement Of Shares For US$15 Million 21
Aerocrine Completes Rights Offering Of Common Stock For US$36 Million 22
Aerocrine Completes Private Placement Of US$16 Million 23
Aerocrine Completes Rights Issue Of US$19 Million 24
Debt Offering 25
Aerocrine Completes Private Placement Of Convertible Bonds For US$16 Million 25
Acquisition 27
Circassia Pharma to Acquire Aerocrine for USD216 Million 27
Aerocrine AB - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Strategy And Business Planning 32
Sep 29, 2014: Aerocrine and Microsoft collaborate to test secure, cloud-based remote medical device monitoring 32
Financial Announcements 33
Feb 20, 2015: Aerocrine Achieves Record Sales for the 4th Quarter and Full Year 33
Jan 07, 2015: Aerocrine Reports Record Sales for the 4th Quarter and Full Year 2014 34
Nov 27, 2014: Aerocrine Interim Report January - September 2014 35
Nov 27, 2014: Interim report January September 2014 36
Jul 24, 2014: Aerocrine Interim report January- June 2014 37
Corporate Communications 38
Jun 26, 2015: Aerocrine applies for delisting 38
Apr 16, 2015: Changes in Aerocrine’s Executive Leadership Team 39
Dec 12, 2014: Aerocrine announces change in the board of directors 40
Jun 12, 2014: Aerocrine Announces Leadership Changes 41
Jun 11, 2014: Aerocrine Announces Management Changes 42
Product News 43
Apr 22, 2015: Aerocrine: Sales start of NIOX VERO in Japan 43
Mar 06, 2015: Aerocrine Receives FDA Clearance for NIOX VERO BlueTooth Wireless Enhancement 44
Jan 29, 2015: Aerocrine Receives Japanese Health Authority Clearance For NIOX VERO 45
Dec 15, 2014: Aerocrine resumes sales and marketing of NIOX MINO in China after re-registration approval 46
Nov 06, 2014: Aerocrine's Niox Vero Device Gets FDA Marketing Clearance 47
Jul 02, 2014: New clinical review gives practising physicians’ recommendations for how to use Aerocrine’s FeNO-test in routine clinical practice 48
Apr 02, 2014: Aerocrine: NICE Recommends the Use of NIOX MINO to Help Diagnose and Manage Asthma 49
Apr 02, 2014: Aerocrine: NICE Recommends the Use of NIOX VERO to Help Diagnose and Manage Asthma 51
Mar 21, 2014: NICE Will Support the Use of Aerocrine’s NIOX VERO In Diagnosis and Management of Asthma 53
Mar 21, 2014: NICE Will Support the Use of Fractional Exhaled Nitric Oxide Measurement in Diagnosis and Management of Asthma 54
Product Approvals 55
Mar 06, 2015: Aerocrine Receives FDA Clearance for NIOX VERO BlueTooth Wireless Enhancement 55
Jan 29, 2015: Aerocrine Receives Japanese Health Authority Clearance For NIOX VERO 56
Nov 06, 2014: Aerocrine's Niox Vero Device Gets FDA Marketing Clearance 57
Clinical Trials 58
Jul 02, 2014: New clinical review gives practising physicians’ recommendations for how to use Aerocrine’s FeNO-test in routine clinical practice 58
Other Significant Developments 59
May 12, 2015: Aerocrine Sales Grow to Record Levels Again for 1st Quarter, NIOX VERO Launch in the US Off to A Strong Start 59
Jan 17, 2014: Aerocrine signs UK & Irish partnership deal with Healthcare 21. 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61
List Of Tables
Aerocrine AB, Medical Equipment, Key Facts, 2014 1
Aerocrine AB, Medical Equipment, Deals Summary, 2009 to YTD 2015 1
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Aerocrine AB, Medical Equipment Deals By Type, 2009 to YTD 2015 7
Aerocrine AB, Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Aerocrine AB, Deals By Market, 2009 to YTD 2015 9
Aerocrine AB, Medical Equipment, Deals Summary, 2009 to YTD 2015 10
Aerocrine Acquires FENO Assets From FILT 11
Aerocrine Completes Acquisition Of Assets From Apieron 12
Aerocrine Enters Into Licensing Agreement With Medisoft 13
Aerocrine Enters Into Distribution Agreement With Shanghai Pharma For Niox Mino And Test Kits 14
Aerocrine Enters Into Distribution Agreement With Stallergenes For Niox Mino 16
Aerocrine To Terminate Distribution Agreement With Thermo Fisher For Niox Mino 18
Aerocrine Enters Into Co-Development Agreement With FILT 19
Aerocrine Enters Into Co-Development Agreement With Panasonic Shikoku Electronics 20
Aerocrine Completes Private Placement Of Shares For US$15 Million 21
Aerocrine Completes Rights Offering Of Common Stock For US$36 Million 22
Aerocrine Completes Private Placement Of US$16 Million 23
Aerocrine Completes Rights Issue Of US$19 Million 24
Aerocrine Completes Private Placement Of Convertible Bonds For US$16 Million 25
Circassia Pharma to Acquire Aerocrine for USD216 Million 27
Aerocrine AB, Key Competitors 29
Aerocrine AB, Key Employees 30
Aerocrine AB, Subsidiaries 31
List Of Figures
Aerocrine AB, Medical Equipment, Deals by Type, 2009 to YTD 2015 1
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015 1
Aerocrine AB, Medical Equipment, Deals By Region, 2009 to YTD 2015 1
Aerocrine AB, Medical Equipment, Deals By Market, 2009 to YTD 2015 1
Aerocrine AB, Medical Equipment, Deals By Year, 2009 to YTD 2015 6
Aerocrine AB, Medical Equipment, Deals by Type, 2009 to YTD 2015 7
Aerocrine AB, Medical Equipment, Deals By Region, 2009 to YTD 2015 8
Aerocrine AB, Medical Equipment, Deals by Market, 2009 to YTD 2015 9
